Top 25 Biotech Angel Investors in China (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Jan Hammer
Angel
|
4 | China, United States, France | Series A, Series B, Seed | Health Care, Medical, Medical Device | $2.8M–$231M |
|
Bingqiang Gao
Angel
|
2 | China, Hong Kong, United States | Seed, Series A, Angel | Robotics, Electronics, Manufacturing | $1.3M–$43M |
|
Mr. Xie Youbang
Angel
|
1 | China | Seed | Health Care, Biotechnology, Pharmaceutical | |
|
Yan Zhao
Angel
|
1 | China | Angel | Biotechnology, Manufacturing, Product Research | |
|
Cai Xiang Scott
Angel
|
1 | China | Series A | Medical, Health Care, Biotechnology | |
|
Liu Xinrong
Angel
|
1 | China | Series A | Beauty, Wellness, Biotechnology | |
|
Jin Haiwei
Angel
|
1 | China | Nutrition, Biotechnology, Manufacturing | ||
|
Mr. Fang Ying
Angel
|
1 | China | Seed | Health Care, Biotechnology, Pharmaceutical | |
|
Suzhou Juming
Angel
|
1 | China | Series A | Biotechnology | |
|
Woyong Fund
Angel
|
1 | China | Seed, Series A | Beauty, Medical, Lifestyle | |
|
James Yahui
Angel
|
1 | China | Series A | Software, Health Care, Biotechnology | |
|
Fu Xin
Angel
|
1 | China | Series B, Seed | Big Data, Manufacturing, Energy | $7.9M–$14M |
|
Tan Ruiqing
Angel
|
1 | China | Series A, Venture - Series Unknown | Biotechnology, Manufacturing, Food and Beverage | |
|
Ye Huahua
Angel
|
1 | China | Seed | Medical, Health Care, Biotechnology | |
|
Shen Yousheng
Angel
|
1 | China | Angel, Series B | Medical, Biotechnology, Therapeutics | |
|
Mr. He Haichao
Angel
|
1 | China | Seed | Health Care, Biotechnology, Pharmaceutical | |
|
Hua Guoping
Angel
|
1 | China | Series A | Biotechnology, Manufacturing, Health Diagnostics | |
|
Gong Hongjia
Angel
|
1 | China | Angel, Seed, Series B | Biotechnology, Medical, Life Science | $1.4M–$14M |
|
Qi Chen
Angel
|
1 | China | Angel | Livestock, Animal Feed, Biotechnology | |
|
Xiao Hongxing
Angel
|
1 | China | Series A | Biopharma, Health Care, Biotechnology | |
|
Jason Zeng
Angel
|
1 | United States, China, France | Seed, Angel, Series B | Internet, Social Media, Machine Learning | $500k–$3.6M |
|
Yi Shuishuishan
Angel
|
1 | China | Series A | Medical, Biopharma, Health Care | |
|
Jiang Guangce
Angel
|
1 | China | Seed | Biopharma, Biotechnology, Pharmaceutical | |
|
Huang Hao
Angel
|
1 | China | Angel | Medical, Biotechnology, Manufacturing | |
|
Mr. Zheng Xiaodong
Angel
|
1 | China | Series A, Series B | Biotechnology, Medical, Hospital | |
| Access all 48 angel investors in China Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Jan Hammer is the partner at Index and the Board observer of Harmonic. Jan attended Oxford University.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B, Seed
- Geography: China, United States, France
Investor stats
- Total investments: 113
- Round size: Seed $2.8M–$15M; Series A $2.8M–$35M; Series B $14M–$231M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Transak — Transak offers a simple integration to allow your users to buy more than 100+ cryptocurrencies with credit/debit cards, or bank transfers in more than 120+ countries.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
- Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.
Bingqiang Gao is the Independent Non-Executive Director of Q Tech.
Show more...Investment focus
- Industry: Robotics, Electronics, Manufacturing
- Stage:Seed, Series A, Angel
- Geography: China, Hong Kong, United States
Investor stats
- Total investments: 29
- Round size: Seed $1.3M–$43M; Angel $1.5M–$2.8M; Series A $10M–$28M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Urtopia — Urtopia is a New Urban Utopia, where passionate people get inspired by innovation and design, and pursue an active lifestyle with high-tech products.
- Blue Emergence — Blue Emergence is a marine technology consumer products company,
- Zhongjian Technology — Zhongjian Technology provides computers, telecommunication, and other electronic devices.
Mr. Xie Youbang founding partner of Jinwell Fund.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.
Yan Zhao
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Product Research
- Stage:Angel
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Zeno Biotech — Zeno Technology is a technologically advanced business that concentrates on harnessing synthetic biology to produce natural products with added value. It has created items using fermentation engineering and synthetic biology. The company primarily targets Saccharomyces cerevisiae, E. coli, and other chassis microorganisms genetically usingnew-generation gene editing technology like CRSPR-Cas9, as well as industrializing the by-products of these strains through fermentation and isolation methods.
Cai Xiang Scott
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Maitong Biopharmaceutical — Maitong Bio is an anti-tumor drug developer it engages in the development of new small molecule targeted anti-tumor drugs.
Liu Xinrong is the Chairman and General Manager of Jiahe Food Industry Co., Ltd.
Show more...Investment focus
- Industry: Beauty, Wellness, Biotechnology
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Giant Microbiology — Giant Microbiology is a company that produces synthetic biological raw materials in an environmentally friendly manner for the fields of beauty and daily chemicals, functional foods, and medical beauty.. The business focuses on creating "high-gross-profit innovative products" that satisfy consumer demand and offer useful, cutting-edge rawmaterial solutions, with bioactive sugars serving as its starting point. Hyaluronic acid, oligosaccharides, and functional oligosaccharides are among the goods it primarily develops and produces.
Jin Haiwei is an investor of Tai'an Hanwei Group
Show more...Investment focus
- Industry: Nutrition, Biotechnology, Manufacturing
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Tai'an Hanwei Group — Tai'an Hanwei Group is a research company that develops and produces biopharmaceuticals and nutritional products.
Mr. Fang Ying, founding partner of Jinwell Fund.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.
Suzhou Juming
Show more...Investment focus
- Industry: Biotechnology
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Zion Pharma — Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.
Woyong Fund is an individual investor.
Show more...Investment focus
- Industry: Beauty, Medical, Lifestyle
- Stage:Seed, Series A
- Geography: China
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- PAM2L Biotechnologies — Boyin Bio is an innovative biomaterial research and development and application enterprise.
- May Micromarketing — May Micromarketing is a beauty short video MCN organization with a team of people, editors, editors and operations. In the logic of the Redskins, May Beauty is mainly to learn from the existing explosions, and to make original content for their own characteristics and advantages.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Zhou Yahui is the founder and Chairman of Kunlun. He previously worked at Thousand Oaks Group as a senior director and vice president. Zhou Yahui attended Tsinghua University.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- NeoCura — NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.
Fu Xin works as a Partner of Sequoia Capital China.
Show more...Investment focus
- Industry: Big Data, Manufacturing, Energy
- Stage:Series B, Seed
- Geography: China
Investor stats
- Total investments: 6
- Round size: Series B $7.9M–$14M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Gongye Technology — Gongye Technology makes use of AI and big data to manufacture intelligent equipment for solid waste sorting and recycling.
- Zechuang Tiancheng — Zechuang Tiancheng is a SaaS-level clinical research digital platform to provide solutions for clinical research.
- Lianyuan Intelligence — Shanghai Lianyuan Intelligent is an innovative energy Internet comprehensive value-added service provider jointly invested by the world's leading new energy companies and executives of the world's top 500 power industry and consulting companies.
Mr. Tan Ruiqing is an individual investor.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Food and Beverage
- Stage:Series A, Venture - Series Unknown
- Geography: China
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Weiyuan Synthetic Biotechnology — Weiyuan Synthetic Biotechnology specializes in the manufacturing of food, feed and materials based on synthetic biology technology.
Ye Huahua is an Angel investor.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ruier Weikang — Ruier Weikang focuses on the development and commercialization of brain scientific disease diagnostic, monitoring, and therapy products.
Shen Yousheng is an individual investor.
Show more...Investment focus
- Industry: Medical, Biotechnology, Therapeutics
- Stage:Angel, Series B
- Geography: China
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Imbioray — Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases. The company engages in the development of global CAR-NK and tiNK cell therapy drugs and is committed to solving the treatment of clinically unmet diseases.
- Torrey Pines Medicine — Torrey Pines Medicine is a biotechnology business focused on creating next-generation ultra-long-acting peptide therapies for metabolic illnesses.
Mr. He Haichao, Chairman of Jinwell Machinery and Chairman of Jinwell Fund
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.
Hua Guoping is based out of Jiangyin, Jiangsu and is the founder of Hualan Pharmaceutical New Materials.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Health Diagnostics
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Boyi Biotechnology — Boyi Biotechnology is a technology-based firm that provides vital raw materials and complete solutions to biomedical customers in the in vitro diagnostic market. It focus on diagnostic microspheres, testing raw materials, and quality control products.
Gong Hongjia is the the founder of Jiadao Capital.
Show more...Investment focus
- Industry: Biotechnology, Medical, Life Science
- Stage:Angel, Seed, Series B
- Geography: China
Investor stats
- Total investments: 11
- Round size: Angel $1.4M–$14M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- KMAX — KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine.
- Snow Origin — Snow Origin is a Beijing deep-tech company specializing in neural interfaces and surface EMG (sEMG) interaction. They build BCI peripheral hardware to deliver natural, stable human-computer interaction for next-generation AR/VR headsets and smart devices.
- CapitalBio Pharma — CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation.
Qi Chen is the Founder and Chief Executive Officer at Mogujie. Mogujie started out as a social site where users created photo collages of fashion items. Now it is a fashion e-commerce platform where the company makes money from merchants paying commissions. A videogame enthusiast who majored in computer science, Chen, who joined Alibaba in2004, helped design the interface of Alibaba’s shopping site, Taobao, including a system that allows merchants to monitor transactions. He came up with the idea of a fashion-themed e-commerce site after seeing the heavy traffic generated by his wife’s fashion blog. Chen Qi quit his software engineering job at Chinese e-commerce giant Alibaba Group Holding Ltd. in 2010 to start an Internet venture he financed by selling all of his Alibaba shares for $500,000. Mogujie now has nearly 100 million users, but Chen declined to comment on whether it is profitable. Alibaba has approached Mogujie about buying a stake, according to Chen, but he says he wants his startup to stay independent. Alibaba declined to comment. Qi is a graduate (B.S.) from the Computer Science and Technology Department of Zhejiang University.
Show more...Investment focus
- Industry: Livestock, Animal Feed, Biotechnology
- Stage:Angel
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Jimi Bio — Jimo Bio is a research and development company of cell-cultured meat.
Xiao Hongxing is the Chairman of Guangzhou Guanghe Technology Co., Ltd. (Delton Technology), a prominent dual-listed printed circuit board manufacturer based in Guangzhou.
Show more...Investment focus
- Industry: Biopharma, Health Care, Biotechnology
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MingCeler — MingCeler is a Bio-Island Laboratory incubation enterprise focused on developing TurboMice™ tetraploid compensation technology. It provides high-end, fast, and excellent model biological technology services and resources for pharmaceutical companies, vaccine companies, universities, research institutes, hospitals, and other life and health-relatedresearch teams.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jason Zeng, one of the Core Founders and Advisor Emeritus of Tencent Group. Jason founded the Group in 1999. As the Chief Operating Officer during 1999 and 2007, Jason was responsible for overseeing the Company's business lines and product portfolios and the managing the Company’s sales and marketing activities across China. Prior toTencent, Jason worked in the Shenzhen Data Telecommunications Bureau and was familiar with the Internet and telecommunications industries in China. Since June 2007, Jason has been the Advisor Emeritus of the Company.
Show more...Investment focus
- Industry: Internet, Social Media, Machine Learning
- Stage:Seed, Angel, Series B
- Geography: United States, China, France
Investor stats
- Total investments: 10
- Round size: Seed $500k–$3.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lyxia China — Lyxia is a biotechnology corporation founded in the State of Delaware at 2012, providing a pioneer technology platform to harness the prolific biofuel yield from microalgae. Lyxia:registered: homes in the desired breakthrough for the current bottleneck of large scale fuel and protein production, and further turns these renewable resource intocommercial oil.
- Hommily — Hommily is a new peer to peer social travel network helping connect travelers to locals from around the globe. Hommily makes it easy to connect with locals for tours, events, drivers, and activities during your trip.
- Quivr — Quivr empowers you to take control of your digital identity, making it easier to connect with a community that truly shares your passions and values.
Yi Shuishuishan
Show more...Investment focus
- Industry: Medical, Biopharma, Health Care
- Stage:Series A
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Alioth — Elios focuses on the development and application of technical products for pharmaceutical process technology.
Dr. Jiang Guangce is the chairman of Dechuan Medical Fund.
Show more...Investment focus
- Industry: Biopharma, Biotechnology, Pharmaceutical
- Stage:Seed
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Renjing Biology — Renjing Biotech is committed to the research and development of innovative drugs based on messenger ribonucleic acid (mRNA).
Huang Hao is the chairman of Yuanxu Fund.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Angel
- Geography: China
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Yiweisen — Yiweisen is a research and development firm that manufactures functional natural compound raw materials.
Mr. Zheng Xiaodong is the Chairman of Tofflon.
Show more...Investment focus
- Industry: Biotechnology, Medical, Hospital
- Stage:Series A, Series B
- Geography: China
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
- Hengyu Biotechnology — Hengyu Biotechnology is a CXO platform founded by a scientific research team that provides biosafety testing and related process validation.
Biotech Angel investor funding in China at a glance
Stats across 60 deals from 48 investors.
Access all 48 angel investors in China Biotech startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech Angel Investors in China investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48 angel investors investing in China Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!